Clavaric Acid

Clavaric Acid

SCHEMBL3471580

C[C@H](CCC(O)C(C)(C)O)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)C[C@@H](OC(=O)CC(C)(O)CC(=O)O)C(=O)C(C)(C)C1CC3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 3/20 1.00
FNTB P49356 3/20 1.00
CRYAB P02511 4/20 0.50
MAPT P10636 3/20 0.46
MEN1 O00255 1/20 0.46
PLA2G1B P04054 1/20 0.46
DNMT1 P26358 1/20 0.46
BLM P54132 1/20 0.46
KMT2A Q03164 1/20 0.46
ATG4B Q9Y4P1 1/20 0.46
CRYAA P02489 1/20 0.44
USP2 O75604 2/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 2/20 0.42
ALOX15 P16050 2/20 0.42
ACHE P22303 1/20 0.42
PIN1 Q13526 2/20 0.41
PTGES O14684 1/20 0.41
PREP P48147 1/20 0.41
BACE1 P56817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clavaric Acid SCHEMBL8897544 1.00 FNTA (1.00) FNTAFNTBCRYABMAPTMEN1
SCHEMBL29934605 0.87 FNTA (0.77) FNTAFNTBCRYABMAPTCRYAA
Clavarinone SCHEMBL606234 0.83 FNTA (1.00) FNTAFNTBCRYABMAPTMEN1
Clavarinone SCHEMBL606233 0.83 FNTA (1.00) FNTAFNTBCRYABMAPTMEN1
SCHEMBL15934993 0.78 CRYAB (0.78) FNTAFNTBCRYABMAPTMEN1
SCHEMBL29934735 0.75 FNTA (0.60) FNTAFNTBCRYABMAPTCRYAA
SCHEMBL5664605 0.75 USP2 (0.73) FNTAFNTBCRYABMAPTCRYAA
SCHEMBL29692186 0.73 CRYAB (0.77) FNTAFNTBCRYABMAPTCRYAA
SCHEMBL17428538 0.73 FNTA (0.67) FNTAFNTBCRYABMAPTCRYAA
SCHEMBL17431762 0.73 CRYAB (0.77) FNTAFNTBCRYABMAPTCRYAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996035707-A1 TERPENOID INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1996-11-14 WO claimed
WO-2010134939-A2 MAMMALIAN GENES INVOLVED IN INFECTION Zirus, Inc. (US) 2010-11-25 WO disclosed
US-5703067-A USEFUL IN THE TREATMENT OF CANCER MERCK & CO., INC. (US) 1997-12-30 US disclosed
WO-1996035707-A1 TERPENOID INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1996-11-14 WO disclosed